These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

527 related items for PubMed ID: 20407458

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Impact of economic, regulatory, and patent policies on innovation in cancer chemoprevention.
    Grabowski HG, Moe JL.
    Cancer Prev Res (Phila); 2008 Jul; 1(2):84-90. PubMed ID: 19138940
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Using market-exclusivity incentives to promote pharmaceutical innovation.
    Kesselheim AS.
    N Engl J Med; 2010 Nov 04; 363(19):1855-62. PubMed ID: 21047231
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. How should we support pharmaceutical innovation?
    Grootendorst P.
    Expert Rev Pharmacoecon Outcomes Res; 2009 Aug 04; 9(4):313-20. PubMed ID: 19670991
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Does process excellence handcuff drug development?
    Koenig J.
    Drug Discov Today; 2011 May 04; 16(9-10):377-81. PubMed ID: 21349347
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Patents: a threat to innovation?
    Manocaran M.
    Science; 2010 Jan 01; 327(5961):31-2; author reply 32. PubMed ID: 20044557
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Open innovation: public-private partnerships in pharmaceutical R&D].
    Uchibayashi N.
    Nihon Yakurigaku Zasshi; 2013 Jul 01; 142(1):32-8. PubMed ID: 23842226
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Trends in risks associated with new drug development: success rates for investigational drugs.
    DiMasi JA, Feldman L, Seckler A, Wilson A.
    Clin Pharmacol Ther; 2010 Mar 01; 87(3):272-7. PubMed ID: 20130567
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Re-engineering drug discovery and development.
    FitzGerald GA.
    LDI Issue Brief; 2011 Oct 01; 17(2):1-4. PubMed ID: 22049582
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.